Search Results

11 - 20 of 29 items :

Clear All
Alternative grains in nutrition

-Bensemra, M. C. Courtin, A. J. Delcour, B. Nadjemi, Assessment of Algerian sorghum protein quality [Sorghum bicolor (L.) Moench] using amino acid analysis and in vitro pepsin digestibility. Food Chemistry, 121. (2010) 719–723. [12] T. Németh, A tápanyagellátás hatása a silócirok (Sorghum bicolor L./Moench) tópelem-felvételére, szárazanyag-felhalmozására és terméshozamára. (Effect of nutrient supply on nutrient uptake, dry matter accumulation and yield of sweet sorghum (Sorghum bicolor L./Moench)). Debreceni Egyetem, Novenytudomdnyi Intezet, Debrecen, (2009

Open access
What’s new about symptomatic reflux disease

appropriate controls, of gastric acid and pepsin secretion in clinical esophagitis. Gastroenterol. 1991;101:1149-58. 10. Bardhan KD, Muller-Lissner S, Bigard MA, et al. Symptomatic gastrooesophageal reflux disease: double blind controlled study of intermittent treatment with omeprazole or ranitidine. The European Study Group. BMJ. 1999;318:502-7. 11. Miner P Jr, Katz PO, Chen Y, et al. Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole: a fiveway crossover study. Am J Gastroenterol 2003

Open access
Activity and stability of urease enzyme immobilized on Amberlite resin

in uremia, ASAIO Trans 37 (1991) 80-87. [27]. H.K. Al-Hakeim, K. Jasem, High ionic strength enhances the anti-pepsin activity of titanium dioxide nanoparticles, Nano Biomed. Eng. 8 (2016) 136-143. [28]. S. Dumitriu, M. Popa, V. Artenie, F. Dan, Bioactive polymers. 56: Urease immobilization on carboxymethylcellulose, Biotechnol. Bioeng. 34 (1989) 283-290.

Open access
Swallowing disorders after treatment for head and neck cancer

. 23 An interesting finding of the present study is a connection between dysphagia and the symptoms of gastroesophageal reflux. Reflux of gastric acid and pepsin is well-recognized etiologic factor in dysphagia even in subjects without cancer, simply by causing inflammation of the laryngeal and hypopharyngeal mucosa. 24 , 25 Such inflammation can additionally aggravate pre-existing radiomucositis in irradiated patients, leading to scarring and impaired sensitivity of involved mucosa. Reflux to the level above the upper esophageal sphincter was found to impair the

Open access
Adsorption and inactivation of proteolytic enzymes by Triaenophorus nodulosus (Cestoda)

parasitizing the fi sh intestine on the activity of the host proteinases. Biol. Bull., 43: 146 - 151. DOI: 10.1134/S1062359016010076 KAGEYAMA, T. (1998): Molecular cloning, expression and characterization of an Ascaris inhibitor for pepsin and cathepsin E. Eur. J. Biochem., 253: 804 - 809. DOI: 10.1046/j.1432-1327.1998.2530804.x KLIMENKO, V., ĶĔNIŅA, V. (1971): On the influence of phylogeny and ecology on some biochemical mechanisms of helminth adaptation. Latvijas Zinatnu akademijas vestis, 11: 93 - 96. (In Russian) KNOX, D

Open access
Diabetes-mediated changes in rat type i collagen and spermatogenesis indices

Biochem 71:114-118, 1976 12. Rubin AL, Drake MP, Davison PF et al. Effect of pepsin on the interaction properties of tropocollagen macromolecules. Biochemistry 4: 181-190, 1965. 13. Maurer G. The Disk-electrophoresis, Mir, Moscow, p. 247, 1971 (in Russian). 14. Deveni T, Gherghey J. The amino-acids, peptides and proteins, Mir, Moscow, p. 364, 1976 (in Russian). 15. Boekelheide K, Chapin R. Male reproductive toxicology . In Current Protocols in Toxicology , Costa LG, Hodgson E, Lawrence DA, Ozolins

Open access
Salivary Theranostics in Pediatric and Special Care Dentistry

metallic dental materials. Comput Appl Electr Eng, 2015;13:143-152. 21. Hashizume N, Fukahori S, Asagiri K, Ishii S, Saikusa N, Higashidate N et al. The characteristics of salivary pepsin in patients with severe motor and intellectual disabilities. Brain Dev, 2017;39:703-709. 22. Reddihough D. Management of drooling in neurological disabilities: more evidence is needed. DMCN, 2017;59:460-461. 23. Siqueira, WL, Bermejo PR, Mustacchi Z. Buffer capacity, pH, and flow rate in saliva of children aged 2–60 months with Down syndrome. Clin Oral Invest, 2005

Open access
Antioxidant Activity of Hydrolysates Prepared from Flaxseed Cake Proteins Using Pancreatin

. Valdez-Ortiz A., Fuentes-Gutierrez CI., German-Baez L.J. Gutierrez-Dorado R, Medina-Godoy S., Protein hydrolysates obtained from Azufrado (sulphur yellow) beans (Phaseo-lus vulgaris): Nutritional, ACE-inhibitory and antioxidative characterization. LWT-Food Sci. Technol., 2012, 46, 91-96. 35. Zambrowicz A., Timmer M., Eckert E., Trziszka T, Evaluation of the ACE-inhibitory activity of egg-white proteins degraded with pepsin. Pol. J. Food Nutr. Sci., 2013, 63, 103-108. 36. Zhang M.-N, Huang G.-R, Jiang J.-X., Iron binding capacity of dephytinised soy protein

Open access
Research Note. Prevalence, protein analysis and possible preventive measures against zoonotic anisakid larvae isolated from marine Atherina fish

, C.V. (2004): Infections related to the ingestion of seafood. Part II: parasitic infections and food safety. Lancet Infect. Dis., 4: 294 - 300. DOI: 10.1016/S1473-3099(04)01005-9 CABALLERO, M.L., MONEO, I. (2004): Several allergens from Anisakis simplex are highly resistant to heat and pepsin treatments. Parasitol. Res., 93: 248 - 251. DOI: 10.1007/s00436-004-1099-3 CARBALLEDA-SANGIAO, N., OLIVARES, F., RODRIGUEZ-MAHILLO, A.I., CARECHE, M., TEJADA, M., MONEO, I., GONZALEZ-MUNOZ, M. (2014): Identifi cation of autoclave

Open access
Review article. Diagnosis and management of venomous snakebites in Southeast Asia

between safety and biochemical characteristics of antivenoms. Toxicon. 1999; 37:895-908. 30. Otero-Patiño R, Cardoso JL, Higashi HG, Nunez V, Diaz A, Toro MF, et al. A randomized, blinded, comparative trial of one pepsin-digested and two whole IgG antivenoms for Bothrops snake bites in Uraba, Colombia. The Regional Group on Antivenom Therapy Research (REGATHER). Am J Trop Med Hyg. 1998; 58:183-9. 31. Boyer LV, Seifert SA, Cain JS. Recurrence phenomena after immunoglobulin therapy for snake envenomations: Part 2. Guidelines for clinical

Open access